Hongxing Liu Selected Research

Hongxing Liu Research Topics

Disease

15	Neoplasms (Cancer) 12/2021 - 01/2017
8	Stomach Neoplasms (Stomach Cancer) 01/2022 - 10/2016
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 02/2011
3	Disease Progression 06/2021 - 01/2020
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021 - 01/2009
2	Hypertension (High Blood Pressure) 10/2021 - 01/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2020
2	Absence Epilepsy (Childhood Absence Epilepsy) 01/2019 - 03/2014
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 01/2018
1	Bacterial Infections (Bacterial Infection) 08/2022
1	Dysbiosis 08/2022
1	AIDS-Related Complex (ARC) 05/2022
1	Philadelphia Chromosome 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 10/2021
1	Hypoxia (Hypoxemia) 09/2021
1	Hyperthermia 07/2021
1	Residual Neoplasm 04/2021
1	Rupture 07/2020
1	Bloom Syndrome 01/2020
1	Inflammation (Inflammations) 01/2020
1	Epileptic Syndromes 01/2019
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2019
1	Adenocarcinoma 10/2018
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Leukemia 01/2018
1	Chronic Neutrophilic Leukemia 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Lymphoma (Lymphomas) 11/2017
1	Pneumonia (Pneumonitis) 10/2017
1	Infections 10/2017
1	Hemorrhage 10/2017
1	Anastomotic Leak 10/2017

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 10/2021 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2016
3	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2020
3	Long Noncoding RNAIBA 01/2022 - 01/2018
3	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2017
2	ruxolitinibIBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2017
2	Peptides (Polypeptides)IBA 01/2021 - 12/2020
2	SeleniumIBA 01/2021 - 07/2020
2	CytokinesIBA 01/2020 - 01/2020
2	Biological ProductsIBA 01/2019 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 12/2018 - 10/2016
2	PerforinIBA 11/2017 - 02/2011
1	Sulfides (Thioethers)IBA 08/2022
1	FluoridesIBA 05/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2021
1	Minor Histocompatibility AntigensIBA 12/2021
1	Therapeutic UsesIBA 10/2021
1	4-phenylbutyric acid (Buphenyl)FDA Link 10/2021
1	LipidsIBA 10/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2021
1	lenvatinibIBA 09/2021
1	Ethylene Glycol (Monoethylene Glycol)IBA 07/2021
1	Phosphorus (Red Phosphorus)IBA 07/2021
1	Transcription Factors (Transcription Factor)IBA 06/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 02/2021
1	Metal-Organic FrameworksIBA 02/2021
1	AntigensIBA 02/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 02/2021
1	CytosineIBA 02/2021
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 02/2021
1	Phosphates (Orthophosphate)IBA 02/2021
1	GuanineIBA 02/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	IntegrinsIBA 01/2021
1	rhodiolosideIBA 12/2020
1	apatinibIBA 12/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2020
1	Polysaccharides (Glycans)IBA 07/2020
1	LentinanIBA 07/2020
1	fms-Like Tyrosine Kinase 3IBA 01/2020
1	erucylphosphocholineIBA 01/2020
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2019
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	SurvivinIBA 12/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 11/2017
1	Qa-SNARE Proteins (Syntaxin)IBA 11/2017

Therapy/Procedure

9	Therapeutics 01/2022 - 06/2016
6	Drug Therapy (Chemotherapy) 04/2021 - 06/2016
4	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2009
3	Stem Cell Transplantation 12/2021 - 01/2020
3	Immunotherapy 04/2021 - 01/2020
2	Lasers (Laser) 07/2021 - 02/2021
2	Gastrectomy 02/2019 - 10/2018
2	Neoadjuvant Therapy 10/2018 - 10/2017
1	Electrodes (Electrode) 10/2021
1	Denervation 10/2021
1	Sympathectomy (Sympathectomies) 01/2021
1	Radiotherapy 01/2020
1	Operative Surgical Procedures 02/2019
1	Adjuvant Chemotherapy 10/2018
1	Conservative Treatment 10/2017